Skip to main content

Animal Disease Diagnostic Laboratory – Able to Detect UK Variant of COVID-19 Virus

Gloved hands disinfect a sample tube with other sample tubes in a stand in the background
Dr. Geoffrey Lossie, avian diagnostician and clinical assistant professor, is a pathologist involved in receiving samples sent to the ADDL. The primary transport containers are disinfected and the samples are prepared to be taken to the Molecular Diagnostic Section of the facility for testing. (Purdue University photo/John Underwood)

Innovators at Purdue’s Animal Disease Diagnostic Laboratory (ADDL) have used their expertise to make the on-campus testing facility one of the only labs in Indiana actively looking for and able to detect the UK variant of the COVID-19 virus. This ability, combined with the university’s data-driven testing approach, has made it possible for cases to be caught, thereby stopping any potential spread among the campus community.

The current PCR test run at the ADDL detects three viral gene targets – two of which must be positive to call the sample positive for SarsCoV2. Identification of the UK (B117) variant strain begins at the point of the ADDL’s analysis of the sample, where one of the three targets, the “S gene,” is absent while the other two gene targets are observed. This “S drop” pattern is a hallmark pattern in the B117 variants, but not all S drops are actually the variant – many are the original strain. When S drop is noted, the sample is sent to another lab on campus for whole genome sequencing of the virus. Sequencing results are typically available in two days and reveal any mutations or changes in the virus’s RNA, which can indicate a COVID-19 variant. All S drop samples detected at Purdue are sent to the Indiana State Department of Health, which then forwards the samples to the CDC.

More than 55,000 tests have been conducted since January 1. Of just over 1,000 positive tests in the spring semester, five cases of the UK COVID-19 variant have been confirmed in the Purdue campus community. The cases were detected as part of the university’s robust testing and contact tracing protocol and in collaboration with the Tippecanoe County Health Department and the Indiana Department of Health.

Four cases of the UK variant were detected in students during pre-arrival testing for the spring semester — two were roommates, and the other two unrelated. Each was arriving to campus from an international location. As previously announced, all students were required to have a negative test before the beginning of classes, and all students traveling internationally were and are required to quarantine before accessing campus. The four pre-arrival positives for the UK variant were discovered during that quarantine period. Contact tracing found that there was no spread due to the quarantine plan. The fifth case was recently identified in an individual who works in health care off campus. They have undergone isolation and contact tracing as well.

The Protect Purdue Chief Medical Officer, Dr. Esteban Ramirez, has discussed the presence of the variant and quarantine efforts during live-streamed Purdue Provost’s Conversations and during public Tippecanoe County Health Department briefings. “Our unique internal testing ability made us fortunate and able to catch the initial cases before returning to campus,” Dr. Ramirez said. “PPHC has not yet seen any difference in the severity in the small number of variant cases we have detected.”

Campus leaders, in consultation with the Protect Purdue Medical Advisory Team and Tippecanoe County health leaders, are examining closely the latest available evidence on the COVID-19 virus and newly reported strains, which also have been detected elsewhere in Indiana. Per the CDC, these new strains, which appear to spread more easily among individuals, do not appear to lead to more severe illness or increased risk of death at this time.

Importantly, all current strategies for mitigating the spread of the virus remain the most effective tools in protecting ourselves, others, and the Purdue’s community: the de-densification of classrooms and workspaces, physical distancing, avoiding large gatherings, the correct and consistent use of face masks, robust personal hygiene, staying home when sick, promptly isolating the infected and quarantining those in close contact for further evaluation, avoiding unnecessary travel, and proactively pursuing testing when activities or interactions suggest risk of exposure. Diligent adherence to the Protect Purdue Pledge — even in one’s shared residence and when off-campus or off-the-clock — is critically important, now more than ever.

Updates on testing numbers are posted daily on the Protect Purdue dashboard.  More information is available on the Protect Purdue website.

Writer(s): Tim Doty, Purdue News Service | pvmnews@purdue.edu

Recent Stories

“Paws Up” for Jennifer Danaher – brought to you by the PVM Wellness Committee

This week we express our gratitude to Jennifer Danaher, who is department secretary for Veterinary Clinical Sciences.

‘Purdue Pursuits’: A PVM angle on Purdue’s teaching and learning reading groups

Crafting meaningful and engaging course experiences has been at the top of Dielson Vieira’s mind ever since he joined the Purdue University College of Veterinary Medicine’s faculty in 2024. As a clinical assistant professor in the Department of Basic Medical Sciences, Vieira is already adept at applying innovative teaching practices to classroom environments, but that doesn’t stop him from seeking out new ideas, approaches and perspectives — insights he gains through outlets like Purdue’s teaching and learning reading groups.

Top tier biology journal publishes PVM study that unlocks secrets of a drug-resistant fungal pathogen, which causes serious infections in humans

Though the name “Candida auris” is far from a household term, public health experts know it well because the multi-drug-resistant fungal pathogen, which causes serious human infections, has been classified as an urgent threat by the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Threats Report (2019). Dr. Shankar Thangamani, Associate Professor of Microbiology and University Faculty Scholar in the Purdue University College of Veterinary Medicine’s Department of Comparative Pathobiology, is researching C. auris, aided by a 2.4 million grant from the National Institutes of Health (NIH). New research findings, just published in Nature Microbiology, show how C. auris adapts and evades the immune system.

In Print: ‘Translational Research Methods for Tauopathies’

A just-published 300-page volume edited by Jessica Fortin, Purdue assistant professor in the College of Veterinary Medicine’s Department of Basic Medical Sciences, provides a significant new resource for researchers studying a group of neurodegenerative diseases known as tauopathies. “Translational Research Methods for Tauopathies” provides detailed protocols intentionally selected to serve as a basis for research laboratories seeking to further treatments for such debilitating neurodegenerative diseases as Alzheimer’s and chronic traumatic encephalopathy (CTE).

It’s Almost Here!

Though the annual Purdue Veterinary Conference is almost upon us, there’s still time to register and take advantage of this time-honored College of Veterinary Medicine fall tradition that combines excellent continuing education with fun opportunities for reconnecting with colleagues and classmates, networking, and learning about the latest veterinary trends and products. The 2026 Purdue Veterinary Conference takes place September 23–26 on the Purdue University campus. The annual event has something for everyone, from veterinarians to veterinary technicians, faculty, staff and students.